Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy

被引:0
|
作者
Karin Weissenborn
Georg Berding
Herbert Köstler
机构
[1] Hochschule Hannover,Department of Neurology, Medizinische
[2] Medizinische,Department of Nuclear Medicine
[3] Hochschule Hannover,Department of Neuroradiology, Medizinische
[4] Hochschule Hannover,undefined
关键词
D; dopamine receptor; dopamine transporter; hepatic encephalopathy;
D O I
10.1007/BF02674526
中图分类号
学科分类号
摘要
A patient suffering from liver cirrhosis presented with a bradykinetic-rigid syndrome suspected as Parkinson's disease. A detailed work-up of the case revealed hepatic encephalopathy as the cause of the neurological symptomatology. An alteration of striatal dopamine D2 receptor binding and dopamine re-uptake sites was demonstrated by123I-iodobenzamide (IBZM) and123I-ß-CIT single photon emission computed tomography (SPECT), respectively. It is suggested that the alteration of the dopamine re-uptake in cirrhotics may be the cause of an increased catabolism of dopamine in HE.
引用
收藏
页码:173 / 178
页数:5
相关论文
共 50 条
  • [1] Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy
    Weissenborn K.
    Berding G.
    Köstler H.
    Metabolic Brain Disease, 2000, 15 (3) : 173 - 178
  • [2] Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy
    Weissenborn, K
    Berding, G
    Köstler, H
    METABOLIC BRAIN DISEASE, 2000, 15 (03) : 173 - 178
  • [3] SELECTIVE LOSS OF PALLIDAL DOPAMINE-D(2) RECEPTOR DENSITY IN HEPATIC-ENCEPHALOPATHY
    MOUSSEAU, DD
    PERNEY, P
    LAYRARGUES, GP
    BUTTERWORTH, RF
    NEUROSCIENCE LETTERS, 1993, 162 (1-2) : 192 - 196
  • [4] Reversible decrease of dopamine D2 receptor density in the striatum of rats with acute hepatic failure
    Waskiewicz, J
    Fresko, I
    Lenkiewicz, A
    Albrecht, J
    BRAIN RESEARCH, 2001, 900 (01) : 143 - 145
  • [5] Altered dopamine D2 receptor binding in atypical facial pain
    Hagelberg, N
    Forssell, H
    Aalto, S
    Rinne, JO
    Scheinin, H
    Taiminen, T
    Någren, K
    Eskola, O
    Jääskeläinen, SK
    PAIN, 2003, 106 (1-2) : 43 - 48
  • [6] Varenicline increases striatal dopamine D2/3 receptor binding in rats
    Crunelle, Cleo L.
    Miller, Michelle L.
    de Bruin, Kora
    van den Brink, Wim
    Booij, Jan
    ADDICTION BIOLOGY, 2009, 14 (04) : 500 - 502
  • [7] Targeting the dopamine D2 receptor in schizophrenia
    Seeman, Philip
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (04) : 515 - 531
  • [8] D2 DOPAMINE RECEPTOR LOCALIZATION ON STRIATONIGRAL NEURONS
    ARIANO, MA
    STROMSKI, CJ
    SMYKRANDALL, EM
    SIBLEY, DR
    NEUROSCIENCE LETTERS, 1992, 144 (1-2) : 215 - 220
  • [9] Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor
    Tillerson, Jennifer L.
    Caudle, W. Michael
    Parent, Jack M.
    Gong, C.
    Schallert, Timothy
    Miller, Gary W.
    BEHAVIOURAL BRAIN RESEARCH, 2006, 172 (01) : 97 - 105
  • [10] Striatal dopamine D1 and D2 receptors in burning mouth syndrome
    Hagelberg, N
    Forssell, H
    Rinne, JO
    Scheinin, H
    Taiminen, T
    Aalto, S
    Luutonen, S
    Någren, K
    Jääskeläinen, S
    PAIN, 2003, 101 (1-2) : 149 - 154